Marshall Wace LLP raised its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 33.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,097,714 shares of the company's stock after purchasing an additional 276,765 shares during the quarter. Marshall Wace LLP owned approximately 0.65% of Option Care Health worth $25,467,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of OPCH. Murphy & Mullick Capital Management Corp acquired a new stake in shares of Option Care Health in the 4th quarter valued at $26,000. UMB Bank n.a. increased its stake in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after buying an additional 346 shares during the period. Signaturefd LLC increased its stake in shares of Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after buying an additional 1,005 shares during the period. Quadrant Capital Group LLC increased its stake in shares of Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after buying an additional 1,099 shares during the period. Finally, Sterling Capital Management LLC increased its holdings in Option Care Health by 638.5% in the fourth quarter. Sterling Capital Management LLC now owns 2,954 shares of the company's stock valued at $69,000 after purchasing an additional 2,554 shares during the last quarter. Institutional investors own 98.05% of the company's stock.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on OPCH shares. Barrington Research reiterated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research report on Monday. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. JMP Securities reiterated a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a research report on Tuesday. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and an average price target of $33.75.
Check Out Our Latest Research Report on Option Care Health
Insiders Place Their Bets
In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.64% of the company's stock.
Option Care Health Stock Performance
OPCH stock traded up $0.08 during midday trading on Thursday, reaching $32.19. 842,553 shares of the company were exchanged, compared to its average volume of 1,780,373. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The business has a 50-day moving average price of $33.33 and a two-hundred day moving average price of $28.70. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The firm has a market capitalization of $5.29 billion, a price-to-earnings ratio of 27.05, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
